These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 32255127)

  • 81. Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging.
    Li Z; Hu Y; Howard KA; Jiang T; Fan X; Miao Z; Sun Y; Besenbacher F; Yu M
    ACS Nano; 2016 Jan; 10(1):984-97. PubMed ID: 26655250
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
    Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coat.
    Nkanga CI; Ortega-Rivera OA; Steinmetz NF
    Nanomedicine; 2022 Aug; 44():102573. PubMed ID: 35728739
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy.
    Guan X; Lin L; Chen J; Hu Y; Sun P; Tian H; Maruyama A; Chen X
    J Control Release; 2019 Jan; 293():104-112. PubMed ID: 30476528
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Combined photothermal-immunotherapy
    Huang X; Tian X; Zhang Q; Hu H; Gao J; Ma B; Wu K; Bai J; Du S; Lu Y; Han N
    Biomater Sci; 2021 Sep; 9(18):6282-6294. PubMed ID: 34378577
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy.
    Yue J; Mei Q; Wang P; Miao P; Dong WF; Li L
    J Nanobiotechnology; 2022 Apr; 20(1):181. PubMed ID: 35392911
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quercetin-ferrum nanoparticles enhance photothermal therapy by modulating the tumor immunosuppressive microenvironment.
    Li L; Zhang M; Liu T; Li J; Sun S; Chen J; Liu Z; Zhang Z; Zhang L
    Acta Biomater; 2022 Dec; 154():454-466. PubMed ID: 36243377
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy.
    Lee CK; Atibalentja DF; Yao LE; Park J; Kuruvilla S; Felsher DW
    Nanotheranostics; 2022; 6(3):243-255. PubMed ID: 35145835
    [No Abstract]   [Full Text] [Related]  

  • 89. Polydopamine Coated Single-Walled Carbon Nanotubes as a Versatile Platform with Radionuclide Labeling for Multimodal Tumor Imaging and Therapy.
    Zhao H; Chao Y; Liu J; Huang J; Pan J; Guo W; Wu J; Sheng M; Yang K; Wang J; Liu Z
    Theranostics; 2016; 6(11):1833-43. PubMed ID: 27570554
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Activating CD8
    Wang B; Zhou J; Li R; Tang D; Cao Z; Xu C; Xiao H
    Adv Mater; 2024 May; 36(21):e2311640. PubMed ID: 38341667
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The Remarkable Anti-Breast Cancer Efficacy and Anti-Metastasis by Multifunctional Nanoparticles Co-Loading Squamocin, R848 and IR 780.
    Wang X; Liu X; Guo Y; Gong T; Lu W; Han M; Guo Y; Wang X
    Int J Nanomedicine; 2024; 19():4679-4699. PubMed ID: 38803997
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Combined chemo-immuno-photothermal therapy based on ursolic acid/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine inhibiting the growth and metastasis of non-small cell lung cancer.
    Xu F; Li M; Que Z; Su M; Yao W; Zhang Y; Luo B; Li Y; Zhang Z; Tian J
    J Mater Chem B; 2023 Apr; 11(15):3453-3472. PubMed ID: 37009696
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy.
    Li JH; Huang LJ; Zhou HL; Shan YM; Chen FM; Lehto VP; Xu WJ; Luo LQ; Yu HJ
    Acta Pharmacol Sin; 2022 Nov; 43(11):2749-2758. PubMed ID: 35484402
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Spatiotemporal-Controlled NIR-II Immune Agonist Sensitizes Cancer Immunotherapy.
    Guo S; Tang D; Zhang M; Yang H; Zhang T; Hu B; Xu C; Weng Y; Shang K; Huang Y
    Adv Mater; 2024 Jun; 36(25):e2400228. PubMed ID: 38477852
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors.
    Xiao G; Zhao Y; Wang X; Zeng C; Luo F; Jing J
    Front Immunol; 2023; 14():1279221. PubMed ID: 37942337
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Reprogramming the Tumor Microenvironment through Second-Near-Infrared-Window Photothermal Genome Editing of PD-L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy.
    Tang H; Xu X; Chen Y; Xin H; Wan T; Li B; Pan H; Li D; Ping Y
    Adv Mater; 2021 Mar; 33(12):e2006003. PubMed ID: 33538047
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Near-Infrared II Nanoadjuvant-Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD-L1 Blockade to Enhance Antitumor Immunity.
    Xiang Q; Yang C; Luo Y; Liu F; Zheng J; Liu W; Ran H; Sun Y; Ren J; Wang Z
    Small; 2022 Apr; 18(13):e2107809. PubMed ID: 35143709
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Combining dual-targeted liquid metal nanoparticles with autophagy activation and mild photothermal therapy to treat metastatic breast cancer and inhibit bone destruction.
    Shen Y; Zou Y; Bie B; Dong C; Lv Y
    Acta Biomater; 2023 Feb; 157():578-592. PubMed ID: 36442822
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers.
    Chen L; Zhou L; Wang C; Han Y; Lu Y; Liu J; Hu X; Yao T; Lin Y; Liang S; Shi S; Dong C
    Adv Mater; 2019 Dec; 31(52):e1904997. PubMed ID: 31721331
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer.
    Zhao Y; Liu X; Liu X; Yu J; Bai X; Wu X; Guo X; Liu Z; Liu X
    Front Immunol; 2022; 13():955920. PubMed ID: 36119019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.